SQZ Biotech is a company that develops transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. It uses its technology, Cell Squeeze, to physically squeeze cells through a microfluidic chip, temporarily opening the cell membrane and enabling biologic material of interest, or cargo, to diffuse into the cell. This technology allows the company to create a pipeline of product candidates for different diseases.
|HQ||Watertown, MA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (13-May-2022)
Closing stock price (13-May-2022)
|Company Name||Date||Deal Size|
|SQZ Biotechnologies Security Corporation|
SQZ Biotech revenue breakdown by business segment: 96.1% from Collaboration and 3.9% from Other
SQZ Biotech has 637 Twitter Followers. The number of followers has increased 2% month over month and increased 4.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was SQZ Biotech founded?
SQZ Biotech was founded in 2013.
Who are SQZ Biotech key executives?
SQZ Biotech's key executives are Armon Sharei, Howard Bernstein and James Douberley.
How many employees does SQZ Biotech have?
SQZ Biotech has 101 employees.
What is SQZ Biotech revenue?
Latest SQZ Biotech annual revenue is $21 m.
What is SQZ Biotech revenue per employee?
Latest SQZ Biotech revenue per employee is $207.9 k.
Who are SQZ Biotech competitors?
Competitors of SQZ Biotech include Ultivue, Onconova Therapeutics and Cleveland BioLabs.
Where is SQZ Biotech headquarters?
SQZ Biotech headquarters is located at 200 Arsenal Yards Blvd, Watertown.
Where are SQZ Biotech offices?
SQZ Biotech has an office in Watertown.
How many offices does SQZ Biotech have?
SQZ Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies